Samsung Biologics CEO John Rim Adds 10 Subscription Rights, Shareholding Unchanged

Bitget2026/10/26 07:14

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Samsung Biologics CEO Rim JohnChongbo received 10 subscription rights certificates on October 19, 2026.
Total securities holdings rose to 270 as of October 26, 2026; shareholdings remained unchanged at 260 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Samsung Biologics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261026000214), on October 26, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Samsung Biologics CEO John Rim Adds 10 Subscription Rights, Shareholding Unchanged

You may also like

Crypto prices